SAN FRANCISCO and DALY CITY, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Adaptive Research, an integrated clinical trial site organization…
This represents the first site in Texas; Medical City Frisco to leverage the benefits of HOLO Portal, the world’s first…
- Rare disease company in preclinical development for congenital hyperinsulinism - - Acquisition is strong strategic fit…
CHCM Will Conduct the Ultimate Competency Assessment WorkshopAtlanta, GA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- From March 14 to 17,…
BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…
Cardiac interventional suite at TriHealth Heart & Vascular Institute on the campus at Bethesda North Exam room in the cardiac…
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,…
Strengthens its Commercial Portfolio with the First and Only AMPA Receptor Antagonist Marketed Product for Epilepsy Bolsters Presence in Neuroscience…
- Patients reported clinically meaningful improvements across multiple health-related quality of life measures following 52 weeks of treatment with setmelanotide…
SYMPAZAN® (clobazam) oral film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two…